Metir (LSE:MET) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


What is Metir Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Metir's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

LSE:MET vs COHR, KEYS, GRMN: Margin of Safety % (DCF FCF Based) Comparison

For the Scientific & Technical Instruments subindustry, Metir's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metir Margin of Safety % (DCF FCF Based) vs Hardware Industry

For the Hardware industry and Technology sector, Metir's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Metir's Margin of Safety % (DCF FCF Based) falls into.


Metir Business Description

Address Amy Johnson Way, York Eco Business Centre, York, GBR, YO30 4AG
Metir PLC, formerly Microsaic Systems PLC is principally focused on monitoring water for toxins and pathogens by integrating its wider equipment portfolio with the manufacture of specialized Microtox reagent consumables. The company's micro-mass spectrometer system and Modern Water water testing solutions enables analytical detection and characterization at the point of need, whether within a mobile testing capability, conventional laboratory setting, or within a bioprocessing facility for continuous detection of data at multiple steps. The company has one business segment, being the research, development, and commercialization of scientific instruments.